<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary superior mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> is sometimes preceded by peripheral <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Inherited <z:hpo ids='HP_0001976'>antithrombin-III deficiency</z:hpo> is a recently recognized <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> trait, which is characterized by <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> and <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This case report illustrates many features of both entities and strongly suggest a causal relationship </plain></SENT>
<SENT sid="3" pm="."><plain>While long-term therapy has yet to be established, prophylactic therapy is recommended when asymptomatic individuals with known <z:hpo ids='HP_0001976'>antithrombin-III deficiency</z:hpo> are at increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The efficacy of <z:chebi fb="5" ids="28304">heparin</z:chebi> alone has been unreliable, whereas <z:chebi fb="0" ids="10034">Coumadin</z:chebi> has been encouraging </plain></SENT>
<SENT sid="5" pm="."><plain>Antithrombin-III concentrates are being developed and theoretically should be helpful </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo> or <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> should be suspected of having <z:hpo ids='HP_0001976'>antithrombin-III deficiency</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Such individuals also represent one mechanism to explain "primary" mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
</text></document>